Literature DB >> 29254476

IgA Antibodies Against Gliadin and Tissue Transglutaminase in Dogs With Chronic Enteritis and Intestinal T-Cell Lymphoma.

I Matsumoto1, K Uchida1, K Nakashima2, S Hiyoshi3, J K Chambers1, H Tsujimoto3, H Nakayama1.   

Abstract

Molecular clonality analysis of T-cell receptor (TCR) genes for diagnosing T-cell lymphoma is widely used in veterinary medicine. However, differentiating chronic enteritis (CE) from intestinal lymphoma is challenging because of the incompatibility between histopathologic and clonality analysis results. On the basis of findings that canine intestinal T-cell lymphoma and celiac disease share some common features, we conducted serologic examinations in combination with histopathologic and T-cell receptor clonality analyses in 48 dogs diagnosed with either CE or intestinal lymphoma. Immunoglobulin A (IgA) and immunoglobulin G (IgG) antibodies against gliadin and tissue transglutaminase (tTG) were quantitatively measured using ELISA. The conditions were classified according to the histopathologic diagnosis, clonality analysis, and combined histopathologic/clonality analysis. Histopathologic analysis showed that dogs with intestinal lymphoma were likely to have high levels of serum IgA antibodies against gliadin and tTG, and serum IgG antibodies against tTG. No correlation between the diagnosed groups and control group was observed in the results of the clonality analysis and histopathologic/clonality analysis. It is interesting that dogs with intestinal lymphoma had a higher serum IgA titer against gliadin and tTG than did dogs with CE. These results suggest an association between repetitive inflammatory stimulation by gliadin peptides and subsequent intestinal lymphoma in dogs.

Entities:  

Keywords:  celiac disease; dogs; gliadin; inflammatory bowel disease; intestinal lymphoma; lymphoplasmacytic enteritis; tissue transglutaminase

Mesh:

Substances:

Year:  2017        PMID: 29254476     DOI: 10.1177/0300985817690212

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  3 in total

1.  Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs.

Authors:  Juan Estruch; Jacqueline Johnson; Sarah Ford; Sean Yoshimoto; Tracy Mills; Philip Bergman
Journal:  J Vet Intern Med       Date:  2021-05-07       Impact factor: 3.333

2.  Response to letter regarding "Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs".

Authors:  Juan J Estruch; Jacqueline Johnson; Sarah Ford; Sean Yoshimoto; Tracy Mills; Philip Bergman
Journal:  J Vet Intern Med       Date:  2021-11-26       Impact factor: 3.333

3.  Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.

Authors:  Juan J Estruch; Derren Barken; Nicole Bennett; Donald K Krawiec; Gregory K Ogilvie; Barbara E Powers; Benjamin J Polansky; Michael T Sueda
Journal:  J Vet Intern Med       Date:  2020-04-13       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.